The efficacy, tolerability, and safety of contemporary antidepressants
- PMID: 20371030
- DOI: 10.4088/JCP.9058se1c.03gry
The efficacy, tolerability, and safety of contemporary antidepressants
Abstract
A wide variety of antidepressants are available today for treating major depressive disorder. However, like all medical therapies, antidepressants have several limitations that clinicians should consider when choosing treatments for their patients. This article reviews the efficacy, tolerability, and safety of the newer (ie, posttricyclic era) antidepressants. Specifically, overall efficacy and efficacy in relation to specific depressive symptoms and patient subpopulations, as well as in relation to various psychiatric and medical comorbidities, are addressed, along with tolerability profiles with respect to common side effects, including nausea, fatigue, insomnia, somnolence, sexual dysfunction, and weight gain. Finally, the safety profile of these agents is summarized.
Similar articles
-
A review of the assessment of antidepressant-induced sexual dysfunction used in randomized, controlled clinical trials.Pharmacopsychiatry. 2007 Sep;40(5):173-82. doi: 10.1055/s-2007-985881. Pharmacopsychiatry. 2007. PMID: 17874347 Review.
-
Duloxetine in the treatment of major depressive disorder: comparisons of safety and tolerability in male and female patients.J Affect Disord. 2006 Aug;94(1-3):183-9. doi: 10.1016/j.jad.2006.04.006. Epub 2006 Jun 14. J Affect Disord. 2006. PMID: 16780958
-
Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials.Expert Opin Pharmacother. 2009 Dec;10(18):3061-75. doi: 10.1517/14656560903448837. Expert Opin Pharmacother. 2009. PMID: 19954275 Review.
-
Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression.Bipolar Disord. 2008 Dec;10(8):957-68. doi: 10.1111/j.1399-5618.2008.00639.x. Bipolar Disord. 2008. PMID: 19594510 Review.
-
Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.Depress Anxiety. 2007;24(1):41-52. doi: 10.1002/da.20209. Depress Anxiety. 2007. PMID: 16845641 Clinical Trial.
Cited by
-
Chaihu-Shugan-San exerts an antidepressive effect by downregulating miR-124 and releasing inhibition of the MAPK14 and Gria3 signaling pathways.Neural Regen Res. 2018 May;13(5):837-845. doi: 10.4103/1673-5374.232478. Neural Regen Res. 2018. PMID: 29863014 Free PMC article.
-
Physician perception regarding side-effect profile at the onset of antidepressant treatment: a survey of Israeli psychiatrists and primary care physicians.Ann Gen Psychiatry. 2016 Jan 29;15:5. doi: 10.1186/s12991-016-0090-6. eCollection 2016. Ann Gen Psychiatry. 2016. PMID: 26834821 Free PMC article.
-
RE104: Synthesis and Activity of a Novel Serotonergic Psychedelic Prodrug of 4-Hydroxy-N,N-diisopropyltryptamine.ACS Chem Neurosci. 2024 Jun 19;15(12):2386-2395. doi: 10.1021/acschemneuro.4c00058. Epub 2024 May 17. ACS Chem Neurosci. 2024. PMID: 38758589 Free PMC article.
-
Association of Antidepressant Continuation in Pregnancy and Infant Birth Weight.J Clin Psychopharmacol. 2021 Jul-Aug 01;41(4):403-413. doi: 10.1097/JCP.0000000000001410. J Clin Psychopharmacol. 2021. PMID: 34029294 Free PMC article.
-
Pharmacological effects and therapeutic potential of natural compounds in neuropsychiatric disorders: An update.Front Pharmacol. 2022 Sep 15;13:926607. doi: 10.3389/fphar.2022.926607. eCollection 2022. Front Pharmacol. 2022. PMID: 36188551 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical